Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2001, p. 879-882, Vol. 39, No. 3
Departments of Clinical Sciences and Farm
Animal Health and Resource Management, College of Veterinary
Medicine, North Carolina State University, Raleigh, North Carolina
Received 15 September 2000/Returned for modification 29 November
2000/Accepted 21 December 2000
Very recently, Bartonella organisms have been isolated
from large ruminants (deer, elk, and dairy and beef cattle) located in
the United States and in France. In this study, we report the serologic, microbiologic, and molecular findings related to the isolation of a Bartonella species in North Carolina beef
cattle and the detection of nanobacterial antigen using a
commercially available enzyme-linked immunosorbent assay. Between
August 1998 and September 1999, blood was collected from 38 cattle
ranging in age from 1 month to 6.5 years. After a 1-month incubation
period, a Bartonella sp. was isolated on a 5% rabbit blood
agar plate from three of six EDTA blood samples. PCR amplification of
the 16S rRNA gene from all three isolates resulted in a DNA sequence that was 100% identical to that of B. weissii 16S rRNA
(GenBank no. AF199502). By IFA testing, 36 of 38 cattle had antibodies ( Bartonella spp. comprise
an important group of vector-transmitted, intracellular bacterial
pathogens (2). Diverse vectors, including sandflies, lice,
mites, fleas, ticks, and potentially other insects can
transmit these organisms among reservoir hosts (2, 6).
Recently, other investigators have isolated Bartonella spp.
from cattle (Bos domesticus) in Oklahoma and California (5; B. B. Chomel, R. W. Kasten, Y. Yamamoto, C. Chang, T. E. Honadel, and Y. Kikuchi, Abstr. First Int. Conf. Bartonella
Emerg. Pathogens, p. 31, 1999) and from cattle in France (H.-J.
Boulouis, R. Heller, F. Barrat, B. Van Laere, D. Thibault, F. Claro, S. Chastant, E. Plouzeau, A. Lecu, F. Ollivet, J. Rigoulet, X. Legendre, P. Moisson, M. Leclerc-Cassan, B. B. Chomel, and Y. Piemont, 2nd Int. Conf. Emerg. Zoonoses, 61, 1998).
Bartonella spp. have also been isolated from wild ruminants,
including mule deer (Odocoileus hemionus) and elk
(Cervus elaphus) from California and roe deer
(Capreolus capreolus) from France (R. Heller, M. Kubina, G. Delacour, F. Lamarque, G. Van Laere, R. Kasten, et al., Int. Conf.
Emerg. Infect. Dis., p 21.18, 1998).
Although Carrion's disease, caused by B. bacilliformis, and
trench fever, caused by B. quintana, have long-standing
medical histories, several new Bartonella species or
subspecies (Bartonella henselae, B. clarridgeiae, B. elizabethae,
B. vinsonii subsp. berkhoffii and B. vinsonii subsp. arupensis) have been implicated as
human pathogens within the past decade (1, 14, 21). Based upon their very recent recognition, the pathogenic
potential of Bartonella spp. in cattle, as well as in most
other animal species, remains to be clarified. However, accumulating
evidence indicates that Bartonella spp. can cause disease
manifestations in some domestic animal species. In dogs, B. vinsonii subsp. berkhoffii causes granulomatous
lymphadenitis, granulomatous rhinitis, myocarditis, and endocarditis
(3, 4, 19). B. henselae has been associated with peliosis hepatitis in a dog (13). Of comparative
medical interest, B. henselae is the only
Bartonella species that has been associated with peliosis
hepatitis in canine and human patients (13, 14). Despite
the frequent isolation of B. henselae from seemingly
healthy, flea-infested cats, evolving evidence from several
laboratories indicates that B. henselae represents a
previously unrecognized cause of chronic, insidious disease
manifestations in cats (6, 9, 16).
Although their actual existence, is controversial, nanobacteria are
purportedly intracellular pathogens that can persist within intracellular compartments of the host for years (8, 12). Nanobacteria appear to cause a variety of cytotoxic
manifestations in cell culture, a feature that was responsible for
their ultimate discovery (8, 12). Based upon the
respective 16S rRNA gene sequences, Bartonella and
Nanobacterium spp. are members of the alpha subdivision of
the Proteobacteria and purportedly share cross-reacting
epitopes (8, 12). In Europe, Kajander and colleagues have
reported that more than 80% of commercial bovine serum lots contain
Nanobacterium spp. (8, 12). To our knowledge, data related to Nanobacterium infection in cattle is not yet
available from the United States.
In 1997, as a component of ongoing studies related to
Bartonella spp., we detected seroreactivity to B. vinsonii subsp. berkhoffii antigens by
immunofluorescent antibody testing of blood samples obtained from
a beef herd in Wake County, N.C. Initial attempts in our laboratory to
isolate Bartonella spp. from these seroreactive cattle,
using lysis centrifugation or freeze-thaw techniques, were
unsuccessful. Recent documentation of Bartonella bacteremia in cattle from the United States and France renewed efforts in our
laboratory to isolate Bartonella spp. from seroreactive beef cattle on a farm in North Carolina. We now report serologic,
microbiologic, and molecular findings, as related to a
Bartonella sp. that was isolated from North Carolina beef
cattle. We also report the detection of nanobacterial antigen using a
commercially available enzyme-linked immunosorbent assay (ELISA).
Description of the herd.
Between August 1998 and September
1999, blood was collected from 38 cattle ranging in age from 1 month to
6.5 years (mean age, 19.8 months). At the time of sampling, 25 calves
were less than 1 year old, and the remaining 13 samples were obtained
from adult cows ranging in age from 1 to 6.5 years, with a mean age of
4.4 years. The cow-calf herd, which consisted of full-blooded and
crossbred Salers, was established in 1992, when adult cows and a Salers
bull were purchased from another farm in Wake County, N.C. Although
beef cattle were maintained on an adjacent farm, there had been no
introduction of new cattle into the herd between 1992 and September
1999. During this time period, fescue toxicity Microimmunofluorescence assay (IFA).
Using a previously
described technique (19), antigens derived from Vero cell
culture-grown B. vinsonii subsp. berkhoffii and a
Bartonella sp. isolate derived from cow 85 in this study were placed on Teflon-coated multiwell slides and stored at Bacteriological methods.
For isolation of
Bartonella spp., 1 ml of EDTA-anticoagulated blood was
inoculated directly onto a blood agar plate (5% rabbit blood
trypticase soy agar) and incubated for 2 months at 35°C, in 5%
CO2. Isolates were examined for morphological
characteristics by light microscopy.
DNA extraction.
DNA from three isolates obtained from three
different cows was obtained using the QIAamp DNA Blood Minikit (Qiagen
Inc., Valencia, Calif.), as recommended by the manufacturer.
16S rRNA gene amplification by PCR.
Primers PC5A
(5'CCTTGTTACGACTTCACCC) and PO-C (5'AGAGTTTGATCCTGG)
were employed for 16S rRNA gene amplification. Primers were obtained from Integrated DNA Technologies, Inc., in Coralville, Iowa.
PCR cycling parameters for the reactions were 95°C for 10 min, 35 cycles at 94°C for 1 min, 53°C for 1 min, and 72°C for 2 min,
followed by a 72°C extension for 5 min. DNA was analyzed on a 1%
agarose gel, stained with ethidium bromide, and photographed. For PCR,
0.2 mM deoxynucleoside triphosphate, a 1 µM concentration of each
primer, 10 mM Tris HCl (pH 8.3), 50 mM KCl, 0.001% gelatin (wt/vol), 3 mM MgCl2, and 1.25 U. of Ampli Taq Gold (PE Applied Biosystems, Foster City, Calif.) were combined in 50-µl reaction mixtures.
DNA sequencing.
DNA fragments from three isolates were used
directly for DNA sequencing, which was performed at the Central
Sequencing Laboratory, University of North Carolina at Chapel Hill, on
a model 373A DNA sequencer (Applied Biosystems) using the Taq DyeDeoxy
Terminator Cycle Sequencing Kit (Applied Biosystems). All samples were
submitted to the sequencing facility with 70 ng of DNA and 10 pmol of
each primer (Integrated DNA Technologies, Inc [see below]) premixed at a total volume of 20 µl. Bidirectional sequencing was
performed. Forward primers used previously34 were POC
(5'AGAGTTTGATCCTGG), P1
(5'ACTCCTACGGGAGGCAGCAGT), P3MOD (5'ATTAGATACCCTGGTAGTCC), and P4
(5'GAGGAAGGTGGGGATGACGTCAA). Primers used previously in the
reverse direction were PC5A (5'CCTTGTTACGACTTCACCC), PC4
(5'TTGACGTCATCCCCACCTTCCTC), PC3
(5'GGACTACCAGGGTATCTAAT), and PC1
(5'ACTGCTGCCTCCCGTAGGAGT). Each PCR product was
purified with a QIAquick PCR purification kit (Qiagen). The GeneBee
Service, from Moscow State University (www.genebee.msu.su), was used to compare the alignments of the sequences derived from the three cow
isolates. BLAST analysis was used to compare the sequences to other 16S
rRNA gene sequences in GenBank.
Nanobacterial antigen detection by ELISA.
A commercially
available monoclonal antibody kit (ELISA) from Nanobac Oy, Kuopio,
Finland, was used to detect Nanobacterium antigens in
EDTA-anticoagulated plasma or serum samples. Due to limited kit
availability, only a subset of the herd that included 22 cows ranging
in age from 1 month to 6.5 years (mean age, 18.9 months) were tested,
as recommended by the manufacturer. In addition to the kit's negative
control, stored frozen sera from two 13-month-old female
specific-pathogen-free beagles that were raised and maintained in
controlled vector-free conditions were tested as nonbovine controls. In
addition, sera from 30 sick dogs with a wide range of disease
manifestations were also tested. The standards, prepared by the
company, and the test sera were added in the wells, washed with the
buffer supplied by the manufacturer, and allowed to react with the
tracer (horseradish peroxidase-conjugated mouse monoclonal antibody).
Reactors were detected by a substrate solution supplied by the
manufacturer and graded as negative (no reaction), 1+, 2+, 3+, or 4+.
When initially tested by IFA, only 15 of 38 cattle were
seroreactive (
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.3.879-882.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Infection with Bartonella weissii and
Detection of Nanobacterium Antigens in a North Carolina
Beef Herd
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
1:64) to Bartonella weissii (bovine origin) antigens.
Nanobacterial antigen was detected in 22 of 22 serum samples. We
conclude that infection with an organism similar or closely related to
B. weissii can occur in North Carolina cattle and that
although their actual existence is still controversial
Nanobacterium antigens were detected with a commercially
available test kit. The epidemiology, vector biology, and potential
pathogenicity of these organisms in cattle deserve future consideration.
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
characterized by severe
lameness, loss of the tail switch; and edema, swelling, and pain in the
region of the coronary band
was the only serious medical disorder
reported by the owner. Clinical manifestations of fescue toxicity
affected approximately one-third of the herd, with full-blooded Salers
more likely to be severely affected, perhaps reflecting a genetic
susceptibility. During the 7-year period following introduction of the
herd, reproductive performance was considered excellent. There were one
aborted fetus, one calf born dead within the placenta, two instances of
retained placenta, and an occasional dystocia, particularly in
first-calf heifers that were born on the farm. Otherwise, each cow
produced and raised a calf annually.
20°C until used for analyses. Serially diluted sera were added to each well
containing a fixed concentration of antigen. Antibody reactivity was
determined by immunofluorescence using anti-bovine immunoglobulin G
conjugated to fluorescein isothiocyanate. For diagnostic purposes, a
titer of
1:64 was considered indicative of exposure to a
Bartonella sp.
![]()
RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
1:64) to B. vinsonii subsp.
berkhoffii antigens (Table 1).
Repeat testing using a Bartonella sp. isolate obtained from the herd (isolate from cow 85) identified 36 of 38 serum samples as
seroreactive (
1:64) to B. weissii antigens. Reciprocal
titers to B. weissii antigens ranged from 16 to 1,024, whereas cross-reactive reciprocal antibody titers to B. vinsonii subsp. berkhoffii ranged from 16 to only 256. Twenty-one samples that were originally nonseroreactive to B. vinsonii subsp. berkhoffii were subsequently found to
be seroreactive to B. weissii at reciprocal titers of
1:64. Of the 25 calves ranging in age from 1 to 8 months, reciprocal
titers were 64 (n = 1), 128 (n = 8),
256 (n = 7), 512 (n = 6) or 1,024 (n = 3). In the two youngest calves (1 month of
age at the time of sampling), reciprocal titers were 256 and 512, respectively. The distribution of antibody titers in adult cows
(ranging in age from 1 to 6.5 years) was similar to the distribution in
calves that were less than 1 year old. Two of the older cows sampled (cows 9 and 10, both 6.5 years old) had the lowest reciprocal titers
(16 and 32, respectively) detected in the herd, despite the concurrent
isolation of bartonella from cow 10.
TABLE 1.
Results of blood culture, bartonella serology, and
nanobacterial antigen testing in a North Carolina beef
herda
After at least 1 month of incubation, B. weissii was isolated on a 5% rabbit blood agar plate from three of six randomly selected EDTA blood samples. Colonies (n = 1 for cow 85, n = 3 for cow 10, and n = 30 for cow 286) became visible on blood agar plates between 3 and 6 weeks following inoculation. The reciprocal B. weissii IFA titers for cows 85, 10, and 286, at the time of culture, were 512, 32, and 512, respectively. The colonies were small, irregular, approximately 1 to 1.5 mm in diameter, opaque, rough, raised, and white. On subsequent passages, the colonies became smooth and round in appearance. By Gram staining, the microorganisms were found to be small gram-negative rods. Due to the relatively inert nature of bartonella organisms, biochemical characterization was not performed in our laboratory.
PCR amplification and DNA sequencing resulted in at least 1,400 base segments, from each of the three isolates (cows 85, 10, and 286), that were identical to each other and were 100% identical to the 16S rRNA gene of B. weissii (GenBank accession no. AF199502). The GenBank accession number for the 16S rRNA gene sequence derived from the B. weissii isolate from cow 10 is AF291746. As a component of a larger multi-institutional study, all three isolates have been sent to the Centers for Disease Control and Prevention, Atlanta, Ga., for total genomic DNA hybridization and for pan-genomic fragment pattern analysis.
Nanobacterial antigen was detected using a commercially available ELISA kit in 22 of 22 cow plasma or serum samples (Table 1). All 22 samples resulted in very strong (4+) reactions, regardless of the age of the animal or the reciprocal antibody titer to B. wessii antigens. In contrast, nanobacterial antigen was not detected in the serum of two healthy specific-pathogen-free dogs or in sera from 27 of 30 sick dogs with a wide range of disease manifestations. Weak positive reactions (1+ or 2+) were obtained for three dogs evaluated for endocarditis, neutrophilic polyarthritis, or a history of extensive tick exposure, and antibodies to B. vinsonii antigens were detected only in the dog with a history of heavy tick exposure (reciprocal titer, 256).
| |
DISCUSSION |
|---|
|
|
|---|
Recently, Bartonella spp. have been isolated from 5 of
12 (42%) Oklahoma cattle, from 58 of 116 (50%) California cattle, and from 39 of 42 (93%) California mule deer (5). In one
California beef herd, Bartonella was isolated from 25 of 26 bulls (96%) and 22 of 27 (82%) cows, when sampled at a single point
in time. In the present study, B. weissii or a closely
related organism was isolated from 3 of 6 (50%) blood samples. As
previous efforts to isolate a Bartonella sp. from cows in
this herd using lysis centrifugation or freeze-thaw techniques were not
successful, samples from only a subset of the herd were cultured as a
component of this study. As such, colony numbers were extremely low (1, 3, or 30 colonies) in the three cows from which B. weissii
was isolated. As seroprevalence, based upon B. weissii
reciprocal titers of
1:64, was 95%, exposure to the organism appears
to be substantial. Presumably culture of the organism from blood is not
a very sensitive diagnostic technique for the detection of bacteremia.
As illustrated in Table 1, seroprevalence increased from 39 to 95%
when samples were tested against a B. weissii isolate obtained from a cow in the herd, indicating that the use of homologous antigens for serologic testing can be of diagnostic importance.
On an evolutionary basis, cattle have presumably developed a highly sophisticated immunologic response to B. weissii, which may be protective against serious pathology. However, the extent to which this previously unrecognized organism might represent a cofactor in the development of the recurrent disease manifestations, such as fescue toxicity, in this herd or the severe decompensation experienced by some cattle following the stress of prolonged transport should be examined in future seroepidemiologic studies. Although transplacental transmission of B. weissii antibodies or transplacental transmission of the organism was not assessed in this study, calves ranging in age from 1 to 8 months had similar, relatively high titers of antibody to B. weissii. Although there was probably maternal transfer of antibodies through the colostrum, these results appear to support the argument for exposure to a putative vector early in life, followed by chronic infection. Chronic Bartonella bacteremia, months in duration, has been reported in cats (28 months), dogs (14 months), and immunocompetent humans (4 months to perhaps years) (2, 15, 16). Collectively, these observations indicate that Bartonella spp. are highly adapted to causing persistent infection in the animal host. Based upon the high rate of isolation in cattle from Oklahoma (42%), California (50%), and North Carolina (50%), persistent infection seems likely in cattle, as is the case in other animal species (15).
B. weissii, originally isolated from domestic cats, was provisionally described by Regnery and colleagues at the Centers for Disease Control in Atlanta, Ga. (R. Regnery, N. Marano, P. Jameson, E. Marston, D. Jones, S. Handley, C. Goldsmith, and C. Greene, 15th Meet. Am. Soc. Rickettsiol., abstr. 4, 2000). In conjunction with B. henselae, B. clarridgeiae, and B. koehlerae, B. weissii represents the fourth Bartonella species found to infect cats in North America. To date, B. weissii isolates from cats have been obtained from Utah and from Illinois. Unlike B. henselae, B. bacilliformis, B. clarridgeiae, and B. weissii are flagellated bacteria. As most Bartonella species appear to be more highly adapted to a specific host, detection of B. weissii in both cats and cattle may reflect an unusual evolutionary adaptation for this particular Bartonella species. Alternatively, infection in cats may represent an infrequent occurrence rather than adaptation in both cats and cows.
Recently, B. vinsonii subsp. arupensis was isolated from the blood of a febrile encephalopathic cattle rancher who became ill shortly after processing cattle (22). Although presumably infrequent, zoonotic infection obtained while processing or butchering cattle infected with B. weissii or B. vinsonii subsp. arupensis may occur. Epidemiologic studies have shown that seroprevalence to bartonella antigens is higher in veterinarians than in the general public, which may represent an increased risk of exposure associated with more frequent animal contact (17, 18). Based upon the recent discovery of bartonella infection in cattle, a seroprevalence study involving individuals working with cattle or working in meat processing plants might be indicated.
To our knowledge, data related to Nanobacterium infection in cattle are not available from United States. As Nanobacteria purportedly share similar surface antigens with Bartonella spp., there may be serologic cross-reactivity; however, the extent to which cross-reactivity occurs has not been well characterized (11, 12). Because of the potential for serologic cross-reactivity among these two organisms, we tested a subgroup of the herd with a commercially available antigen ELISA test kit. Surprisingly, 100% (22 of 22) of the cattle tested in this herd had very high levels of circulating nanobacterial antigens. In contrast, 29 of 32 dog samples did not contain detectable levels of nanobacterial antigens. Assuming the specificity of the monoclonal antibody for the detection of nanobacterial antigens, these results would support a high rate of nanobacterial infection in this herd. Whether a correlation exists between the detection of nanobacteria antigens and infection with B. weissii in this herd was not determined, due to the presumed relative insensitivity of bartonella blood culture as used in this study.
In humans and experimentally infected laboratory animals, Nanobacteria can cause chronic infection (1, 8, 12). For example, Nanobacteria were reportedly isolated from the blood of one person for five years, despite the concurrent presence of antibodies. Following experimental infection of rabbits with Nanobacteria derived from fetal bovine sera, organisms can be isolated from urine or cerebrospinal fluid for up to 1 year (1, 12). Most recently, a role for Nanobacterium in the development of human kidney stones and polycystic kidney disease has been proposed (8, 10). Future studies should examine the potential relationship between exposure to and infection with Bartonella and Nanobacterium species, the extent to which these organisms might contribute to disease manifestations in cattle and the extent to which cattle might serve as a reservoir for human infection.
| |
ACKNOWLEDGMENTS |
|---|
We thank Barbara Hegarty and Chris Pitulle for helpful discussions.
This project was supported by the State of North Carolina and through formula funds from the U.S. Department of Agriculture.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27606. Phone: (919) 513-6234. Fax: (919) 513-6336. E-mail: ed_breitschwerdt{at}ncsu.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Akerman, K. K., J. T. Kuikka, N. Ciftcioglu, J. Parkkinen, K. A. Bergstrom, I. Kuronen, and E. O. Kajander. 1997. Radiolabeling and in vivo distribution of Nanobacteria in rabbits. Proc. SPIE Int. Opt. Eng. 3111:436-442[CrossRef]. |
| 2. | Anderson, B. E., and M. A. Neuman. 1997. Bartonella spp. as emerging human pathogens. Clin. Microbiol. Rev. 10:203-219[Abstract]. |
| 3. | Breitschwerdt, E. B., D. L. Kordick, D. E. Malarkey, B. Keene, T. H. Hadfield, and K. Wilson. 1995. Endocarditis in a dog due to infection with a novel Bartonella subspecies. J. Clin. Microbiol. 33:154-160[Abstract]. |
| 4. |
Breitschwerdt, E. B.,
C. E. Atkins,
T. T. Brown,
D. L. Kordick, and P. S. Snyder.
1999.
Bartonella vinsonii subspecies berkhoffii and other alpha Proteobacteria associated with cardiac arrhythmias, endocarditis, or myocarditis in dogs.
J. Clin. Microbiol.
37:3618-3626 |
| 5. | Chang, C.-C., B. B. Chomel, R. W. Kasten, R. Heller, K. M. Kocan, H. Ueno, K. Yamamoto, V. C. Bleich, B. J. Gonzales, P. K. Swift, W. M. Boyce, S. S. Jang, H.-J. Boulouis, and Y. Piemont. 2000. Bartonella spp. isolated from wild and domestic ruminants in North America. Emerg. Infect. Dis. 6:306-311[Medline]. |
| 6. | Chomel, B. B., R. W. Kasten, K. Floyd-Hawkins, B. Chi, K. Yamamoto, J. Roberts-Wilson, A. N. Gurfield, R. C. Abbott, N. C. Pederson, and J. E. Koehler. 1996. Experimental transmission of Bartonella henselae by the cat flea. J. Clin. Microbiol. 34:1952-1956[Abstract]. |
| 7. | Ciftcioglu, N., A. Pelttari, and E. O. Kajander. 1997. Extraordinary growth phases of Nanobacteria isolated from mammalian blood. Proc. SPIE Int. Opt. Eng. 3441:429-435. |
| 8. | Ciftcioglu, N., M. Bjorklund, K. Kuorikoski, K. Bergstrom, and E. O. Kajander. 1999. Nanobacteria: an infectious cause of kidney stone formation. Kidney Int. 56:1893-1898[CrossRef][Medline]. |
| 9. | Guptill, L., L. Slater, C. Wu, T. Lin, L. Glickman, D. Welch, and H. HogenEsch. 1997. Experimental infection of young specific pathogen-free cats with Bartonella henselae. J. Infect. Dis. 176:206-216[Medline]. |
| 10. | Hjelle, J. T., M. A. Miller-Hjelle, I. R. Poxton, E. O. Kajander, N. Ciftcioglu, M. L. Jones, R. C. Caughey, R. Brown, P. D. Millikin, and F. S. Darras. 2000. Endotoxin and Nanobacteria in polycystic kidney disease. Kidney Int. 57:2360-2374[CrossRef][Medline]. |
| 11. |
Kajander, E. O., and N. Ciftcioglu.
1998.
Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation.
Proc. Natl. Acad. Sci. USA
95:8274-8278 |
| 12. | Kajander, E. O., I. Kuronen, K. Akerman, A. Pelttari, and N. Ciftcioglu. 1997. Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. Proc. SPIE Int. Opt. Eng. 3441:420-428. |
| 13. | Kitchell, B. E., T. M. Fan, G. Walenberg, D. L. Kordick, and E. B. Breitschwerdt. 2000. Peliosis hepatitis in a dog associated with Bartonella henselae. J. Am. Vet. Med. Assoc. 216:519-523[CrossRef][Medline]. |
| 14. |
Koehler, J. E.,
M. A. Sanchez,
C. S. Garrido,
M. J. Whitfeld,
F. M. Chen,
T. G. Berger,
M. C. Rodriguez-Barradas,
P. E. LeBoit, and J. W. Tappero.
1997.
Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis-peliosis.
N. Engl. J. Med.
337:1876-1883 |
| 15. | Kordick, D. L., and E. B. Breitschwerdt. 1998. Persistent infection of pets within a household with three Bartonella species: Bartonella clarridgeiae, Bartonella henselae, or Bartonella vinsonii subsp. berkhoffii. Emerg. Infect. Dis. 4:325-328[Medline]. |
| 16. |
Kordick, D. L.,
T. T. Brown,
K. Shin, and E. B. Breitschwerdt.
1999.
Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats.
J. Clin. Microbiol.
37:1536-1547 |
| 17. | Noah, D. L., C. M. Kramer, M. P. Verbsky, J. A. Rooney, K. A. Smith, and J. E. Childs. 1997. Survey of veterinary professionals and other veterinary conference attendees for antibodies to Bartonella henselae and B. quintana. J. Am. Vet. Med. Assoc. 210:342-344[Medline]. |
| 18. | Nowotny, N., A. Deutz, K. Fuchs, W. Schuller, F. Hinterdorfer, H. Auer, and H. Aspock. 1997. Prevalence of swine influenza and other viral, bacterial and parasitic zoonoses in veterinarians. J. Infect. Dis. 176:1414-1415[Medline]. |
| 19. | Pappalardo, B. L., M. T. Correa, C. C. York, C. Y. Peat, and E. B. Breitschwerdt. 1997. Epidemiologic evaluation of the risk factors associated with exposure and seroreactivity to Bartonella vinsonii in dogs. Am. J. Vet. Res. 58:467-471[Medline]. |
| 20. | Pappalardo, B. L., T. Brown, J. L. Gookin, C. L. Morrill, and E. B. Breitschwerdt. 2000. Granulomatous disease associated with Bartonella infection in two dogs. J. Vet. Intern. Med. 14:37-42[CrossRef][Medline]. |
| 21. |
Welch, D. F,
K. C. Carroll,
E. K. Hofmeister,
D. H. Persing,
D. A. Robinson,
A. G. Steigerwalt, and D. J. Brenner.
1999.
Isolation of a new subspecies, Bartonella vinsonii subsp. arupensis, from a cattle rancher: identity with isolates found in conjunction with Borrelia burgdorferi and Babesia microti among naturally infected mice.
J. Clin. Microbiol.
37:2598-2601 |
| 22. |
Wilson, K. H.,
R. B. Blitchington, and R. C. Greene.
1990.
Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction.
J. Clin. Microbiol.
28:1942-1946 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|